This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Inglesby T V, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. (2000) Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283:2281–2290.
Perry RD, Fetherston JD (1997) Yersinia pestis—etiologic agent of plague. Clin Microbiol Rev 10:35–66.
Titball RW, Williamson ED (2001) Vaccination against bubonic and pneumonic plague. Vaccine 19:4175–4184.
Anisimov AP, Lindler LE, Pier GB (2004) Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev 17:434–464.
Russell P, Eley SM, Hibbs SE, Manchee RJ, Stagg AJ, Titball RW (1995) A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551–1556.
Meyer KF, Smith G, Foster L, Brookman M, Sung M (1974) Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J Infect Dis 129:S85–S112.
Welkos S, Pitt ML, Martinez M, Friedlander A, Vogel P, Tammariello R (2002) Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20:2206–2214.
Titball RW, Williamson ED (2004) Yersinia pestis (plague) vaccines. Expert Opin Biol Ther 4:965–973.
Brubaker RR (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 71:3673–3681.
Cornelis GR (2000) Molecular and cell biology aspects of plague. Proc Natl Acad Sci USA 97:8778–8783.
Baker EE, Somer H, Foster LW, Meyer E, Meyer KF (1952) Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J Immunol 68:131–145.
Du Y, Rosqvist R, Forsberg A (2002) Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 70:1453–1460.
Marshall JD Jr Bartelloni PJ, Cavanaugh DC, Kadull PJ, Meyer KF (1974) Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine. J Infect Dis 129:S19–S25.
Devdariani ZL, Fedorova VA, Gromova OV, Taranenko TM (1997) Comparative incidence of detection of specific antibodies to Yersinia pestis capsular antigen and lipopolysaccha-ride in humans immunized with pest vaccine. Klin Lab Diagn 4:39–41.
Allen JS, Skowera A, Rubin GJ, Wessely S, Peakman M (2006) Long-lasting T cell responses to biological warfare vaccines in human vaccinees. Clin Infect Dis 43:1–7.
Acknowledgments
We thank Dr. Valentina A. Feodorova for helpful discussions. This work was supported by grant U54 AI0577156 to NIH/NIAID Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this paper
Cite this paper
Braciale, V.L., Nash, M., Sinha, N., Zudina, I.V., Motin, V.L. (2008). Correlates of Immunity Elicited by Live Yersinia pestis Vaccine. In: Georgiev, V.S., Western, K.A., McGowan, J.J. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-569-5_50
Download citation
DOI: https://doi.org/10.1007/978-1-59745-569-5_50
Publisher Name: Humana Press
Print ISBN: 978-1-934115-77-0
Online ISBN: 978-1-59745-569-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)